High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma
Titel:
High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma
Auteur:
Yang, Hannah Kang, Beodeul Ha, Yeonjung Lee, Sung Hwan Kim, Ilhwan Kim, Hyeyeong Lee, Won Suk Kim, Gwangil Jung, Sanghoon Rha, Sun Young Gaillard, Vincent E. Cheon, Jaekyung Kim, Chan Chon, Hong Jae